GHW International (9933.HK)

HKD 2.65

(-0.38%)

EBITDA Summary of GHW International

  • GHW International's latest annual EBITDA in 2023 was 17.34 Million CNY , down -87.31% from previous year.
  • GHW International's latest quarterly EBITDA in 2024 Q2 was 60.47 Million CNY , down 0.0% from previous quarter.
  • GHW International reported an annual EBITDA of 329.43 Million CNY in 2022, up 87.06% from previous year.
  • GHW International reported an annual EBITDA of 176.11 Million CNY in 2021, up 453.19% from previous year.
  • GHW International reported a quarterly EBITDA of -24.54 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • GHW International reported a quarterly EBITDA of N/A for 2023 FY, down -87.31% from previous quarter.

Annual EBITDA Chart of GHW International (2023 - 2016)

Historical Annual EBITDA of GHW International (2023 - 2016)

Year EBITDA EBITDA Growth
2023 17.34 Million CNY -87.31%
2022 329.43 Million CNY 87.06%
2021 176.11 Million CNY 453.19%
2020 31.83 Million CNY -37.49%
2019 50.92 Million CNY -57.69%
2018 120.35 Million CNY -8.47%
2017 134.39 Million CNY 198.71%
2016 44.01 Million CNY 0.0%

Peer EBITDA Comparison of GHW International

Name EBITDA EBITDA Difference
Wai Chun Bio-Technology Limited 14.89 Million HKD -16.464%
Lee & Man Chemical Company Limited 597.01 Million HKD 97.095%